A new study shows that a shorter, less toxic chemotherapy regimen that includes the drug Herceptin appears to be just as effective in women with HER-2 positive breast cancer as using a standard three-drug therapy with Herceptin, a strategy that can be harder on the heart.

Click here to read the full story.

No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.